8-K: BIO-key Trims Operating Loss by $3.5M on 29% Revenue Growth in Preliminary 2023 Results

BIO-key International announced preliminary 2023 results, showing a significant reduction in operating loss and a 29% increase in revenue.

Summary

• BIO-key International reported preliminary financial results for 2023, showing a 29% increase in revenue to $9.1 million, up from $7.0 million in 2022.
• The company reduced its operating loss by approximately $3.5 million due to revenue growth and cost-cutting measures.
• Selling, general, and administrative expenses decreased by 22% or $2.1 million.
• Net cash used in operating activities was reduced by $2.5 million in 2023.
• A $2.8 million reserve was taken against slow-moving hardware inventory, impacting gross profit and margin.
• Despite the inventory reserve, the net loss was reduced by 48% to $(6.2M) or $(11.45) per share, compared to $(12.2M) or $(27.26) per share in 2022.
• The company received a $1.5 million cash payment in Q1 2024 for a 2-year license extension.
• BIO-key has over 600 customers globally and operates primarily on a SaaS or subscription-based model.
• The company is focused on an asset-light go-to-market strategy, leveraging over 150 channel partners.

Sentiment

Score: 7

Explanation: The document shows positive progress with revenue growth and cost reductions, but the significant inventory reserve and continued net loss temper the overall sentiment. The future outlook is positive, but the company still faces challenges.

Positives

• Revenue increased by 29% to $9.1 million, indicating strong sales growth.
• Operating expenses were significantly reduced, with SG&A down by 22% and R&D down by 26%.
• The net loss was reduced by 48%, showing progress towards profitability.
• The company secured a $1.5 million cash payment for a license extension in Q1 2024, improving its financial position.
• BIO-key has a growing global distribution and customer base, positioning it for future growth.
• The company is focused on a SaaS and subscription-based model, providing recurring revenue.

Negatives

• A $2.8 million reserve was taken against slow-moving hardware inventory, impacting gross profit and margin.
• The gross margin declined to 36.5% in 2023 from 65.2% in 2022 due to the inventory reserve.
• The company still reported a net loss of $(6.2M) for 2023, despite improvements.
• The audit of the 2023 financial statements has not been completed, and the figures are subject to change.

Risks

• The company has a history of losses and limited revenue, which may impact its ability to operate.
• BIO-key's ability to raise additional capital to satisfy working capital needs is a risk.
• The company's ability to continue as a going concern is a risk.
• There are risks associated with protecting intellectual property and competition in the biometric technology industry.
• Market acceptance of biometric products and the company's products under development is a risk.
• The company's ability to convert sales opportunities to customer contracts is a risk.
• There are risks associated with expanding into foreign markets and integrating acquisitions.

Future Outlook

BIO-key expects increased deployment of enhanced IAM solutions as enterprises transition to the cloud and respond to cybersecurity vulnerabilities. The company plans to launch Passkey:YOU, a passwordless authentication solution, and aims for meaningful topand bottom-line improvement in 2024, building on recurring revenues and a blended gross margin of approximately 65%. They will also continue to pursue cost reduction initiatives.

Management Comments

• BIO-key CEO, Mike DePasquale, stated that the company made solid progress on its path to profitability in 2023, driven by revenue growth and cost-cutting initiatives.
• He also mentioned that the company looks to build on this record in 2024, focusing on top-line growth opportunities balanced with further efforts to reduce costs.
• Management believes their growing global distribution and customer base puts them in a strong position to reach profitability over the next several quarters.

Industry Context

The announcement aligns with the broader industry trend of increasing adoption of multi-factor authentication (MFA) and passwordless security solutions. The company is positioning itself to capitalize on the growing demand for IAM solutions as enterprises transition to the cloud and face increasing cybersecurity threats. The company is also leveraging the growing adoption of passkey authentication by major tech companies.

Comparison to Industry Standards

• BIO-key's 29% revenue growth is a positive sign, but it is important to compare this to other IAM and cybersecurity companies.
• Companies like Okta, Ping Identity, and CyberArk are key competitors in the IAM space, and their growth rates and financial performance should be considered for context.
• The gross margin of 36.5% is significantly lower than the industry average, which is typically above 60%, due to the inventory reserve. This needs to be addressed to improve profitability.
• The reduction in operating expenses is a positive step, but the company still needs to achieve profitability to be competitive with industry leaders.
• The company's focus on channel partners is a common strategy in the software industry, but its effectiveness needs to be evaluated against competitors' strategies.

Stakeholder Impact

• Shareholders will be encouraged by the revenue growth and reduced losses, but concerned about the inventory reserve and continued losses.
• Employees may be impacted by cost-cutting measures, but the company's growth could provide opportunities.
• Customers will benefit from the company's enhanced IAM solutions and focus on passwordless authentication.
• Suppliers may be impacted by the company's cost-cutting measures.
• Creditors will be encouraged by the improved financial performance, but concerned about the company's history of losses.

Next Steps

• BIO-key will host an investor call on April 2nd to discuss the results.
• The company plans to launch Passkey:YOU, a passwordless authentication solution.
• BIO-key will continue to pursue cost reduction initiatives in 2024.
• The company will explore opportunities to convert the slow-moving inventory into cash.

Key Dates

Keywords

biometrics, identity access management, IAM, cybersecurity, authentication, passwordless, SaaS, revenue growth, cost reduction, financial results